• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Anti-SARS-CoV-2 RBD IgG responses in convalescent versus naïve BNT162b2 vaccine recipients.

作者信息

Azzi Lorenzo, Focosi Daniele, Dentali Francesco, Baj Andreina, Maggi Fabrizio

机构信息

Unit of Oral Medicine and Pathology, ASST dei Sette Laghi, Varese, Italy; Department of Medicine and Surgery, University of Insubria, Varese, Italy.

North-Western Tuscany Blood Bank, Pisa University Hospital, Pisa, Italy.

出版信息

Vaccine. 2021 Apr 28;39(18):2489-2490. doi: 10.1016/j.vaccine.2021.03.086. Epub 2021 Mar 30.

DOI:10.1016/j.vaccine.2021.03.086
PMID:33824042
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8009041/
Abstract
摘要
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/714f/8009041/17c856a020a5/gr1_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/714f/8009041/17c856a020a5/gr1_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/714f/8009041/17c856a020a5/gr1_lrg.jpg

相似文献

1
Anti-SARS-CoV-2 RBD IgG responses in convalescent versus naïve BNT162b2 vaccine recipients.康复者与初次接种BNT162b2疫苗者体内抗SARS-CoV-2 RBD IgG反应。
Vaccine. 2021 Apr 28;39(18):2489-2490. doi: 10.1016/j.vaccine.2021.03.086. Epub 2021 Mar 30.
2
Real-world serological responses to extended-interval and heterologous COVID-19 mRNA vaccination in frail, older people (UNCoVER): an interim report from a prospective observational cohort study.真实世界中衰弱老年人接受延长间隔和异源 COVID-19 mRNA 疫苗接种后的血清学反应（UNCoVER）：一项前瞻性观察队列研究的中期报告。
Lancet Healthy Longev. 2022 Mar;3(3):e166-e175. doi: 10.1016/S2666-7568(22)00012-5. Epub 2022 Feb 23.
3
Evaluation of the SARS-CoV-2 Antibody Response to the BNT162b2 Vaccine in Patients Undergoing Hemodialysis.评估接受血液透析患者对 BNT162b2 疫苗的 SARS-CoV-2 抗体反应。
JAMA Netw Open. 2021 Sep 1;4(9):e2123622. doi: 10.1001/jamanetworkopen.2021.23622.
4
Differences in IgG Antibody Responses following BNT162b2 and mRNA-1273 SARS-CoV-2 Vaccines.BNT162b2 和 mRNA-1273 两种 SARS-CoV-2 疫苗接种后的 IgG 抗体反应差异。
Microbiol Spectr. 2021 Dec 22;9(3):e0116221. doi: 10.1128/Spectrum.01162-21. Epub 2021 Nov 10.
5
Comparative kinetics of SARS-CoV-2 anti-spike protein RBD IgGs and neutralizing antibodies in convalescent and naïve recipients of the BNT162b2 mRNA vaccine versus COVID-19 patients.比较 BNT162b2 mRNA 疫苗接种者的恢复期和未接种者的 SARS-CoV-2 抗刺突蛋白 RBD IgG 和中和抗体与 COVID-19 患者的动力学。
BMC Med. 2021 Aug 23;19(1):208. doi: 10.1186/s12916-021-02090-6.
6
Comparative analyses of IgG/IgA neutralizing effects induced by three COVID-19 vaccines against variants of concern.三种 COVID-19 疫苗对关注变异株诱导的 IgG/IgA 中和效果的比较分析。
J Allergy Clin Immunol. 2022 Apr;149(4):1242-1252.e12. doi: 10.1016/j.jaci.2022.01.013. Epub 2022 Jan 29.
7
Long-term quantitative assessment of anti-SARS-CoV-2 spike protein immunogenicity (QUASI) after COVID-19 vaccination in older people living with HIV (PWH).老年人 HIV 感染者（PWH）接种 COVID-19 疫苗后对 SARS-CoV-2 刺突蛋白免疫原性的长期定量评估（QUASI）。
BMC Infect Dis. 2022 Sep 21;22(1):744. doi: 10.1186/s12879-022-07737-0.
8
Seroresponse to SARS-CoV-2 Vaccines among Maintenance Dialysis Patients over 6 Months.维持性透析患者接种 SARS-CoV-2 疫苗后 6 个月的血清学反应。
Clin J Am Soc Nephrol. 2022 Mar;17(3):403-413. doi: 10.2215/CJN.12250921. Epub 2022 Feb 10.
9
SARS-CoV-2 IgG Spike antibody levels and avidity in natural infection or following vaccination with mRNA-1273 or BNT162b2 vaccines.SARS-CoV-2 IgG 刺突抗体水平和亲和力在自然感染或接种 mRNA-1273 或 BNT162b2 疫苗后。
Hum Vaccin Immunother. 2023 Aug 1;19(2):2215677. doi: 10.1080/21645515.2023.2215677. Epub 2023 Jun 1.
10
Anti-SARS-CoV-2 Immunoglobulin Isotypes, and Neutralization Activity Against Viral Variants, According to BNT162b2-Vaccination and Infection History.根据 BNT162b2 疫苗接种和感染史，抗 SARS-CoV-2 免疫球蛋白同种型和对病毒变异体的中和活性。
Front Immunol. 2021 Dec 17;12:793191. doi: 10.3389/fimmu.2021.793191. eCollection 2021.

引用本文的文献

1
Humoral Immunity of Unvaccinated COVID-19 Recovered vs. Naïve BNT162b2 Vaccinated Individuals: A Prospective Longitudinal Study.未接种疫苗的新冠康复者与单纯接种BNT162b2疫苗者的体液免疫：一项前瞻性纵向研究。
Microorganisms. 2023 Jun 22;11(7):1628. doi: 10.3390/microorganisms11071628.
2
An Immunological Review of SARS-CoV-2 Infection and Vaccine Serology: Innate and Adaptive Responses to mRNA, Adenovirus, Inactivated and Protein Subunit Vaccines.SARS-CoV-2感染与疫苗血清学的免疫学综述：对mRNA、腺病毒、灭活及蛋白亚单位疫苗的固有免疫和适应性免疫反应
Vaccines (Basel). 2022 Dec 26;11(1):51. doi: 10.3390/vaccines11010051.
3

本文引用的文献

1
Safety and Efficacy of the BNT162b2 mRNA Covid-19 Vaccine.BNT162b2 mRNA 新冠病毒疫苗的安全性和有效性。
N Engl J Med. 2020 Dec 31;383(27):2603-2615. doi: 10.1056/NEJMoa2034577. Epub 2020 Dec 10.
2
Durability of Responses after SARS-CoV-2 mRNA-1273 Vaccination.SARS-CoV-2 mRNA-1273疫苗接种后反应的持久性。
N Engl J Med. 2021 Jan 7;384(1):80-82. doi: 10.1056/NEJMc2032195. Epub 2020 Dec 3.
3
Clinical and Analytical Performance of an Automated Serological Test That Identifies S1/S2-Neutralizing IgG in COVID-19 Patients Semiquantitatively.
Use of Self-Collected Dried Blood Spots and a Multiplex Microsphere Immunoassay to Measure IgG Antibody Response to COVID-19 Vaccines.
使用自采干血斑和多重微球免疫分析测定对 COVID-19 疫苗的 IgG 抗体反应。
Microbiol Spectr. 2023 Feb 14;11(1):e0133622. doi: 10.1128/spectrum.01336-22. Epub 2023 Jan 9.
4
Antibody-Dependent Complement Responses toward SARS-CoV-2 Receptor-Binding Domain Immobilized on "Pseudovirus-like" Nanoparticles.针对固定在“类假病毒”纳米颗粒上的严重急性呼吸综合征冠状病毒2（SARS-CoV-2）受体结合域的抗体依赖性补体反应
ACS Nano. 2022 May 4. doi: 10.1021/acsnano.2c02794.
5
Seroconversion panels demonstrate anti-SARS-CoV-2 antibody development after administration of the mRNA-1273 vaccine.血清转化面板显示接种 mRNA-1273 疫苗后抗 SARS-CoV-2 抗体的产生。
Vaccine. 2022 May 11;40(22):2993-2998. doi: 10.1016/j.vaccine.2022.04.006. Epub 2022 Apr 8.
6
Robust Antibody Responses to the BNT162b2 mRNA Vaccine Occur Within a Week After the First Dose in Previously Infected Individuals and After the Second Dose in Uninfected Individuals.在先前感染过的个体中，第一剂后一周内和未感染个体中第二剂后，BNT162b2 mRNA 疫苗会引发强烈的抗体反应。
Front Immunol. 2021 Aug 26;12:722766. doi: 10.3389/fimmu.2021.722766. eCollection 2021.
7
B and T cell response to SARS-CoV-2 vaccination in health care professionals with and without previous COVID-19.医护人员中有无既往 COVID-19 史者对 SARS-CoV-2 疫苗接种的 B 和 T 细胞应答。
EBioMedicine. 2021 Aug;70:103539. doi: 10.1016/j.ebiom.2021.103539. Epub 2021 Aug 12.
8
Antibody response after one and two jabs of the BNT162b2 vaccine in nursing home residents: The CONsort-19 study.养老院居民接种一剂和两剂 BNT162b2 疫苗后的抗体反应：CONsort-19 研究。
Allergy. 2022 Jan;77(1):271-281. doi: 10.1111/all.15007. Epub 2021 Jul 29.
9
Anti-SARS-CoV-2 Receptor-Binding Domain Total Antibodies Response in Seropositive and Seronegative Healthcare Workers Undergoing COVID-19 mRNA BNT162b2 Vaccination.接受新冠病毒mRNA BNT162b2疫苗接种的血清阳性和血清阴性医护人员中抗SARS-CoV-2受体结合域总抗体反应
Diagnostics (Basel). 2021 May 4;11(5):832. doi: 10.3390/diagnostics11050832.
一种用于半定量识别 COVID-19 患者 S1/S2 中和 IgG 的自动化血清学检测的临床和分析性能。
J Clin Microbiol. 2020 Aug 24;58(9). doi: 10.1128/JCM.01224-20.